Product Description
Basic Info.
Retatrutide is an experimental drug developed by Eli Lilly and Company in the United States for the treatment of obesity. It is a triple glucagon hormone receptor agonist.
In a phase II clinical trial, the drug has been proved to reduce the average weight of non diabetes but obese or pre obese (overweight) adults by more than 17.5%
Factory
Well-Equipped Filter Physical and Chemical Laboratory
To solidify product qualityfoundations and establishan industry-leading r&Dand testing system,the companyinvested in2014to
build a wel-equipped, fully-functional provincial-level filter physical and chemical laboratory. Designed and constructed in strict accor-
dance with the highest national and industry standards, the laboratory is outfitted with world-class precision testing instruments and
experimental equipment.
In 2016, leveraging its exceptional quality management capabilities and standardized production operations, the company successfully
achieved ISO/Ts 16949:2009 certification-the most authoritative quality management system recognized by the global automotive in-
dustry--becoming one of the select few enterprises in the sector to earn this distinguished honor.



















